ANIP insider transactions
ANI Pharmaceuticals Inc. (ANIP) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for ANIP
- Director Walsh Patrick D sold $1,127,120 worth of shares (13,973 units at $80.66), decreasing direct ownership by 27% to 38,432 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, HEAD - ESTABLISHED BRANDS Rowland Thomas Andrew sold $36,357 worth of shares (459 units at $79.21), decreasing direct ownership by 1% to 38,271 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- PRESIDENT & CEO Lalwani Nikhil sold $4,266,350 worth of shares (55,000 units at $77.57), decreasing direct ownership by 14% to 349,889 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, GENERICS Gutwerg Ori sold $220,374 worth of shares (2,772 units at $79.50), decreasing direct ownership by 3% to 78,696 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SR. VP, GENERAL COUNSEL & SEC. Cook Meredith sold $39,080 worth of shares (500 units at $78.16) as part of a pre-agreed trading plan, decreasing direct ownership by 0.63% to 78,390 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SEC Form 4 filed by Cook Meredith4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- HEAD OF RARE DISEASE Mutz Christopher sold $226,526 worth of shares (3,162 units at $71.64), decreasing direct ownership by 3% to 91,309 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, HEAD - ESTABLISHED BRANDS Rowland Thomas Andrew sold $357,471 worth of shares (4,772 units at $74.91), decreasing direct ownership by 11% to 38,730 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SR. VP, GENERAL COUNSEL & SEC. Cook Meredith sold $36,310 worth of shares (500 units at $72.62), decreasing direct ownership by 0.63% to 79,390 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- HEAD OF RARE DISEASE Mutz Christopher sold $424,617 worth of shares (5,723 units at $74.19) and covered exercise/tax liability with 3,314 shares, decreasing direct ownership by 9% to 94,471 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- PRESIDENT & CEO Lalwani Nikhil covered exercise/tax liability with 17,060 shares, decreasing direct ownership by 4% to 404,889 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, GENERICS Gutwerg Ori covered exercise/tax liability with 3,314 shares, decreasing direct ownership by 4% to 81,468 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, CHIEF HR OFFICER Davis Krista sold $488,474 worth of shares (6,572 units at $74.33), decreasing direct ownership by 11% to 51,946 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP & CFO Carey Stephen P. covered exercise/tax liability with 5,150 shares, decreasing direct ownership by 3% to 180,393 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP & CFO Carey Stephen P. exercised 3,312 shares at a strike of $49.51 and sold $552,031 worth of shares (7,312 units at $75.50), decreasing direct ownership by 2% to 185,543 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- HEAD OF RARE DISEASE Mutz Christopher sold $30,858 worth of shares (417 units at $74.00), decreasing direct ownership by 0.40% to 103,508 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, GENERICS Gutwerg Ori sold $157,590 worth of shares (2,060 units at $76.50), decreasing direct ownership by 2% to 84,782 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- Director Walsh Patrick D sold $445,380 worth of shares (6,000 units at $74.23), decreasing direct ownership by 10% to 52,405 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- HEAD OF R&D, COO-NOVITIUM OPS Shanmugam Muthusamy was granted 11,116 shares, increasing direct ownership by 12% to 101,056 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, HEAD - ESTABLISHED BRANDS Rowland Thomas Andrew was granted 6,021 shares and covered exercise/tax liability with 628 shares, increasing direct ownership by 14% to 43,502 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- HEAD OF RARE DISEASE Mutz Christopher was granted 21,306 shares and covered exercise/tax liability with 2,221 shares, increasing direct ownership by 22% to 103,925 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- PRESIDENT & CEO Lalwani Nikhil was granted 75,592 shares and covered exercise/tax liability with 12,217 shares, increasing direct ownership by 18% to 421,949 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, GENERICS Gutwerg Ori was granted 12,969 shares and covered exercise/tax liability with 2,221 shares, increasing direct ownership by 14% to 86,842 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP - CORP. DEV. & STRATEGY Gassert Chad was granted 11,116 shares and covered exercise/tax liability with 2,221 shares, increasing direct ownership by 13% to 74,916 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, CHIEF HR OFFICER Davis Krista was granted 10,810 shares and covered exercise/tax liability with 1,555 shares, increasing direct ownership by 19% to 58,518 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SR. VP, GENERAL COUNSEL & SEC. Cook Meredith was granted 13,895 shares and covered exercise/tax liability with 1,555 shares, increasing direct ownership by 18% to 79,890 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP & CFO Carey Stephen P. was granted 22,233 shares and covered exercise/tax liability with 2,773 shares, increasing direct ownership by 11% to 189,543 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- HEAD OF RARE DISEASE Mutz Christopher sold $415,300 worth of shares (5,323 units at $78.02), decreasing direct ownership by 6% to 84,840 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, CHIEF HR OFFICER Davis Krista sold $296,495 worth of shares (3,814 units at $77.74), decreasing direct ownership by 7% to 49,263 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, HEAD - ESTABLISHED BRANDS Rowland Thomas Andrew covered exercise/tax liability with 1,051 shares, decreasing direct ownership by 3% to 38,109 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- HEAD OF RARE DISEASE Mutz Christopher covered exercise/tax liability with 5,576 shares and sold $538,300 worth of shares (7,032 units at $76.55), decreasing direct ownership by 12% to 90,163 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- PRESIDENT & CEO Lalwani Nikhil covered exercise/tax liability with 21,986 shares, decreasing direct ownership by 6% to 358,574 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, GENERICS Gutwerg Ori covered exercise/tax liability with 3,663 shares, decreasing direct ownership by 5% to 76,094 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP - CORP. DEV. & STRATEGY Gassert Chad covered exercise/tax liability with 3,325 shares, decreasing direct ownership by 5% to 66,021 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, CHIEF HR OFFICER Davis Krista covered exercise/tax liability with 2,470 shares, decreasing direct ownership by 4% to 53,077 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SR. VP, GENERAL COUNSEL & SEC. Cook Meredith covered exercise/tax liability with 3,313 shares and sold $38,400 worth of shares (500 units at $76.80), decreasing direct ownership by 5% to 67,550 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP & CFO Carey Stephen P. covered exercise/tax liability with 5,277 shares, decreasing direct ownership by 3% to 170,083 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP & CFO Carey Stephen P. covered exercise/tax liability with 5,503 shares, decreasing direct ownership by 3% to 175,360 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SR. VP, GENERAL COUNSEL & SEC. Cook Meredith covered exercise/tax liability with 3,011 shares, decreasing direct ownership by 4% to 71,363 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, CHIEF HR OFFICER Davis Krista covered exercise/tax liability with 3,017 shares, decreasing direct ownership by 5% to 55,547 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP - CORP. DEV. & STRATEGY Gassert Chad covered exercise/tax liability with 4,269 shares, decreasing direct ownership by 6% to 69,346 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, GENERICS Gutwerg Ori covered exercise/tax liability with 4,267 shares, decreasing direct ownership by 5% to 79,757 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- PRESIDENT & CEO Lalwani Nikhil covered exercise/tax liability with 30,659 shares, decreasing direct ownership by 7% to 380,560 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- HEAD OF RARE DISEASE Mutz Christopher covered exercise/tax liability with 4,546 shares, decreasing direct ownership by 4% to 102,771 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, HEAD - ESTABLISHED BRANDS Rowland Thomas Andrew covered exercise/tax liability with 1,762 shares, decreasing direct ownership by 4% to 39,160 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- HEAD OF R&D, COO-NOVITIUM OPS Shanmugam Muthusamy covered exercise/tax liability with 2,898 shares, decreasing direct ownership by 3% to 89,940 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SR. VP, GENERAL COUNSEL & SEC. Cook Meredith sold $42,165 worth of shares (500 units at $84.33), decreasing direct ownership by 0.67% to 74,374 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, CHIEF HR OFFICER Davis Krista sold $133,653 worth of shares (1,622 units at $82.40), decreasing direct ownership by 3% to 58,564 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SR. VP, GENERAL COUNSEL & SEC. Cook Meredith sold $32,928 worth of shares (400 units at $82.32), decreasing direct ownership by 0.53% to 74,874 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- Director Tannenbaum Renee P sold $146,070 worth of shares (1,800 units at $81.15), decreasing direct ownership by 7% to 25,157 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- Director Walsh Patrick D sold $750,904 worth of shares (8,643 units at $86.88) and gifted 3,000 shares, decreasing direct ownership by 17% to 58,405 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP - CORP. DEV. & STRATEGY Gassert Chad sold $1,312,435 worth of shares (14,736 units at $89.06) (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SR. VP, GENERAL COUNSEL & SEC. Cook Meredith sold $34,908 worth of shares (400 units at $87.27), decreasing direct ownership by 0.53% to 75,274 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SR. VP, GENERAL COUNSEL & SEC. Cook Meredith sold $36,036 worth of shares (400 units at $90.09), decreasing direct ownership by 0.53% to 75,674 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, CHIEF HR OFFICER Davis Krista sold $98,040 worth of shares (1,000 units at $98.04), decreasing direct ownership by 2% to 60,186 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, CHIEF HR OFFICER Davis Krista covered exercise/tax liability with 1,710 shares, decreasing direct ownership by 3% to 61,186 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SR. VP, GENERAL COUNSEL & SEC. Cook Meredith sold $39,368 worth of shares (400 units at $98.42), decreasing direct ownership by 0.52% to 76,074 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- Director Pera Antonio R sold $692,302 worth of shares (7,292 units at $94.94), decreasing direct ownership by 24% to 22,660 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- Director Leonard Matthew J sold $229,087 worth of shares (2,528 units at $90.62), decreasing direct ownership by 27% to 6,864 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, CHIEF HR OFFICER Davis Krista sold $160,609 worth of shares (1,763 units at $91.10), decreasing direct ownership by 3% to 62,896 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)